🔎 Trials Near Me

Akèy › Melanom Uveal › Pennsylvania

Etid klinik pou Melanom Uveal nan Pennsylvania

8 etid pou Melanom Uveal ap chèche patisipan nan sit nan Pennsylvania.

Vil nan Pennsylvania

Tèks ofisyèl etid la (Anglè)

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

  • Wills Eye Hospital at Thomas Jefferson University, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07804186

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

  • UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06070012

Tebentafusp-tebn With LDT in Metastatic UM

  • Thomas Jefferson University, Philadelphia
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT06626516

Neoadjuvant Tebentafusp for Uveal Melanoma

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06414590

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT03947385

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
  • ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • Jefferson Health Honickman Center, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • Thomas Jefferson University, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 2/3
Tout laj · Tout sèks · Mizajou Apr 2, 2026 · NCT06581406

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.